Drug · DIN 02424282
LAYLAA 21
21 DAYS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 10, 2023; first marketed July 6, 2023.
- Drug Identification Number (DIN)
- 02424282
- Company (DIN owner)
- Lupin Pharma Canada LimitedLongueuil, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levonorgestrel and estrogen G03AA07
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVONORGESTREL | 100 MCG | |
| ETHINYL ESTRADIOL | 20 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 10, 2023: NOC 32103Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership. Product name change
- April 29, 2014: NOC 15556Abbreviated New Drug Submission (ANDS)